YHB Investment Advisors Inc. lowered its position in CME Group Inc. (NASDAQ:CME – Free Report) by 4.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 25,378 shares of the financial services provider’s stock after selling 1,045 shares during the quarter. YHB Investment Advisors Inc.’s holdings in CME Group were worth $4,702,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Grayhawk Investment Strategies Inc. purchased a new position in CME Group during the 1st quarter worth $28,000. Power Corp of Canada purchased a new stake in CME Group in the first quarter worth about $26,000. Silicon Valley Capital Partners bought a new position in CME Group during the 1st quarter worth about $27,000. Cascade Investment Advisors Inc. purchased a new position in CME Group during the 1st quarter valued at about $27,000. Finally, MayTech Global Investments LLC purchased a new stake in shares of CME Group in the 4th quarter worth approximately $25,000. Institutional investors own 85.69% of the company’s stock.
Insiders Place Their Bets
In other CME Group news, Director Dennis Suskind sold 1,500 shares of the stock in a transaction dated Monday, November 6th. The stock was sold at an average price of $213.60, for a total transaction of $320,400.00. Following the sale, the director now directly owns 3,167 shares of the company’s stock, valued at approximately $676,471.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, Director Elizabeth A. Cook sold 500 shares of the business’s stock in a transaction on Monday, October 30th. The shares were sold at an average price of $211.43, for a total value of $105,715.00. Following the completion of the transaction, the director now directly owns 19,241 shares in the company, valued at approximately $4,068,124.63. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Dennis Suskind sold 1,500 shares of the company’s stock in a transaction that occurred on Monday, November 6th. The stock was sold at an average price of $213.60, for a total value of $320,400.00. Following the transaction, the director now directly owns 3,167 shares of the company’s stock, valued at $676,471.20. The disclosure for this sale can be found here. In the last ninety days, insiders sold 33,386 shares of company stock valued at $6,844,355. 0.30% of the stock is owned by insiders.
CME Group Stock Performance
CME Group (NASDAQ:CME – Get Free Report) last issued its quarterly earnings results on Wednesday, October 25th. The financial services provider reported $2.25 EPS for the quarter, topping analysts’ consensus estimates of $2.21 by $0.04. The company had revenue of $1.34 billion during the quarter, compared to analysts’ expectations of $1.34 billion. CME Group had a return on equity of 11.70% and a net margin of 57.03%. Sell-side analysts predict that CME Group Inc. will post 9.14 EPS for the current year.
CME Group Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 28th. Investors of record on Friday, December 8th will be issued a $1.10 dividend. The ex-dividend date is Thursday, December 7th. This represents a $4.40 annualized dividend and a yield of 2.08%. CME Group’s dividend payout ratio (DPR) is presently 52.51%.
Wall Street Analyst Weigh In
Several analysts have issued reports on CME shares. Deutsche Bank Aktiengesellschaft increased their target price on CME Group from $224.00 to $240.00 and gave the company a “buy” rating in a research report on Wednesday, October 11th. Rosenblatt Securities lifted their target price on CME Group from $173.00 to $180.00 and gave the company a “sell” rating in a research note on Thursday, October 26th. Citigroup increased their price target on shares of CME Group from $215.00 to $240.00 and gave the company a “buy” rating in a research report on Thursday, October 12th. Barclays reduced their price objective on shares of CME Group from $247.00 to $244.00 and set an “overweight” rating for the company in a research note on Thursday, October 26th. Finally, Morgan Stanley boosted their price objective on shares of CME Group from $215.00 to $220.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 26th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $220.00.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
- Five stocks we like better than CME Group
- Are Penny Stocks a Good Fit for Your Portfolio?
- 5 must-have next-gen technologies that institutions are buying
- Investing in Commodities: What Are They? How to Invest in Them
- 3 intriguing late-week earnings plays for short-term traders
- Stock Analyst Ratings and Canadian Analyst Ratings
- Datadog is about to hit 52-week highs, and there’s more to come
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.